OA11143A - Anti-parasitic action of N,N-diethyl-m-toluamide (deet) and formulations that prolong its activity in the skin - Google Patents
Anti-parasitic action of N,N-diethyl-m-toluamide (deet) and formulations that prolong its activity in the skin Download PDFInfo
- Publication number
- OA11143A OA11143A OA9900175A OA9900175A OA11143A OA 11143 A OA11143 A OA 11143A OA 9900175 A OA9900175 A OA 9900175A OA 9900175 A OA9900175 A OA 9900175A OA 11143 A OA11143 A OA 11143A
- Authority
- OA
- OAPI
- Prior art keywords
- deet
- composition
- skin
- daims
- liposomes
- Prior art date
Links
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 title claims abstract description 155
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 230000002141 anti-parasite Effects 0.000 title claims description 3
- 238000009472 formulation Methods 0.000 title abstract description 30
- 230000000694 effects Effects 0.000 title description 51
- 239000002502 liposome Substances 0.000 claims abstract description 39
- 229960001673 diethyltoluamide Drugs 0.000 claims abstract description 26
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 21
- 201000010099 disease Diseases 0.000 claims abstract description 20
- 241000238631 Hexapoda Species 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 15
- 241000238876 Acari Species 0.000 claims description 29
- 244000045947 parasite Species 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 241000242678 Schistosoma Species 0.000 claims description 15
- 241000242680 Schistosoma mansoni Species 0.000 claims description 15
- 241000255925 Diptera Species 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 9
- 230000000149 penetrating effect Effects 0.000 claims description 9
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 239000002953 phosphate buffered saline Substances 0.000 claims description 8
- 241000238421 Arthropoda Species 0.000 claims description 7
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 208000030852 Parasitic disease Diseases 0.000 claims description 6
- 125000000129 anionic group Chemical group 0.000 claims description 5
- 230000000507 anthelmentic effect Effects 0.000 claims description 5
- 125000002091 cationic group Chemical group 0.000 claims description 5
- 239000000077 insect repellent Substances 0.000 claims description 4
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 3
- 241001448281 Austrobilharzia variglandis Species 0.000 claims description 3
- 241001448190 Gigantobilharzia huronensis Species 0.000 claims description 3
- 241001063205 Stagnicola <basidiomycete> Species 0.000 claims description 3
- 241001590940 Trachusa schoutedeni Species 0.000 claims description 3
- 241001448052 Trichobilharzia ocellata Species 0.000 claims description 3
- 241000331598 Trombiculidae Species 0.000 claims description 2
- 239000003096 antiparasitic agent Substances 0.000 claims description 2
- 150000002327 glycerophospholipids Chemical class 0.000 claims 3
- 241001448187 Ornithobilharzia canaliculata Species 0.000 claims 2
- 241000242677 Schistosoma japonicum Species 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241000282994 Cervidae Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241001124072 Reduviidae Species 0.000 claims 1
- SGPGESCZOCHFCL-UHFFFAOYSA-N Tilisolol hydrochloride Chemical compound [Cl-].C1=CC=C2C(=O)N(C)C=C(OCC(O)C[NH2+]C(C)(C)C)C2=C1 SGPGESCZOCHFCL-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 5
- 230000001846 repelling effect Effects 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract description 3
- 239000000969 carrier Substances 0.000 abstract description 2
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 description 27
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 241000894007 species Species 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 241000237858 Gastropoda Species 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 10
- 201000004409 schistosomiasis Diseases 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 230000003187 abdominal effect Effects 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 239000000693 micelle Substances 0.000 description 8
- 241000255129 Phlebotominae Species 0.000 description 7
- 238000000376 autoradiography Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000003981 vehicle Substances 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 150000003904 phospholipids Chemical class 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000009102 absorption Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000001524 infective effect Effects 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241000256103 Simuliidae Species 0.000 description 4
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 230000001912 cercariacidal effect Effects 0.000 description 4
- 230000005786 degenerative changes Effects 0.000 description 4
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 229960001920 niclosamide Drugs 0.000 description 4
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- -1 Cederol Chemical compound 0.000 description 3
- 241000754688 Cercaria Species 0.000 description 3
- 241000545744 Hirudinea Species 0.000 description 3
- 241000258242 Siphonaptera Species 0.000 description 3
- 208000004374 Tick Bites Diseases 0.000 description 3
- JLPULHDHAOZNQI-JLOPVYAASA-N [(2r)-3-hexadecanoyloxy-2-[(9e,12e)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC JLPULHDHAOZNQI-JLOPVYAASA-N 0.000 description 3
- 201000000652 cercarial dermatitis Diseases 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241001147657 Ancylostoma Species 0.000 description 2
- 241001465677 Ancylostomatoidea Species 0.000 description 2
- 208000009802 Colorado tick fever Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 229920002306 Glycocalyx Polymers 0.000 description 2
- 241000258937 Hemiptera Species 0.000 description 2
- 206010053317 Hydrophobia Diseases 0.000 description 2
- 208000004554 Leishmaniasis Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 206010024238 Leptospirosis Diseases 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- 208000016604 Lyme disease Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 241000498270 Necator americanus Species 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 241001674048 Phthiraptera Species 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 201000009754 Powassan encephalitis Diseases 0.000 description 2
- 206010039207 Rocky Mountain Spotted Fever Diseases 0.000 description 2
- 241000244174 Strongyloides Species 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 208000035056 Tick-Borne disease Diseases 0.000 description 2
- 208000004006 Tick-borne encephalitis Diseases 0.000 description 2
- 206010044608 Trichiniasis Diseases 0.000 description 2
- 208000034784 Tularaemia Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229940124339 anthelmintic agent Drugs 0.000 description 2
- 239000000921 anthelmintic agent Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 229960002903 benzyl benzoate Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229960002380 dibutyl phthalate Drugs 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 208000000292 ehrlichiosis Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000004634 feeding behavior Effects 0.000 description 2
- 201000006592 giardiasis Diseases 0.000 description 2
- 210000004517 glycocalyx Anatomy 0.000 description 2
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 2
- 229960004068 hexachlorophene Drugs 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 201000000827 tick paralysis Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000003982 trichinellosis Diseases 0.000 description 2
- 201000007588 trichinosis Diseases 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- OGLZSMPGMUDNKR-UHFFFAOYSA-N 1-(2-methylphenyl)piperidine Chemical compound CC1=CC=CC=C1N1CCCCC1 OGLZSMPGMUDNKR-UHFFFAOYSA-N 0.000 description 1
- YXTROGRGRSPWKL-UHFFFAOYSA-N 1-benzoylpiperidine Chemical compound C=1C=CC=CC=1C(=O)N1CCCCC1 YXTROGRGRSPWKL-UHFFFAOYSA-N 0.000 description 1
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000257324 Glossina <genus> Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000238703 Ixodes scapularis Species 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 108091005975 Myofilaments Proteins 0.000 description 1
- 241000498271 Necator Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 206010035718 Pneumonia legionella Diseases 0.000 description 1
- 206010036086 Polymenorrhoea Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000255628 Tabanidae Species 0.000 description 1
- 241000327320 Trichobilharzia physellae Species 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000000884 anti-protozoa Effects 0.000 description 1
- 229960000981 artemether Drugs 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000010627 cedar oil Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000003624 condensation of chromatin Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SXYIRMFQILZOAM-HVNFFKDJSA-N dihydroartemisinin methyl ether Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OC)O[C@H]4[C@]32OO[C@@]1(C)O4 SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 description 1
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- 229960001826 dimethylphthalate Drugs 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- SBNKFTQSBPKMBZ-UHFFFAOYSA-N ethenzamide Chemical compound CCOC1=CC=CC=C1C(N)=O SBNKFTQSBPKMBZ-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- AVIYEYCFMVPYST-UHFFFAOYSA-N hexane-1,3-diol Chemical compound CCCC(O)CCO AVIYEYCFMVPYST-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 208000028454 lice infestation Diseases 0.000 description 1
- 235000011475 lollipops Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- TWXANGNDDHVUIU-UHFFFAOYSA-N n,n-diethyl-2,5-dimethylbenzamide Chemical compound CCN(CC)C(=O)C1=CC(C)=CC=C1C TWXANGNDDHVUIU-UHFFFAOYSA-N 0.000 description 1
- PUZORFQMRDHKBT-UHFFFAOYSA-N n,n-diethyl-4-methylbenzamide Chemical compound CCN(CC)C(=O)C1=CC=C(C)C=C1 PUZORFQMRDHKBT-UHFFFAOYSA-N 0.000 description 1
- FSSVIYSWRLKICW-UHFFFAOYSA-N n-ethyl-n-phenylacetamide Chemical compound CCN(C(C)=O)C1=CC=CC=C1 FSSVIYSWRLKICW-UHFFFAOYSA-N 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000007865 relapsing fever Diseases 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000002311 trypanosomiasis Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/10—Insect repellent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4025197P | 1997-02-11 | 1997-02-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11143A true OA11143A (en) | 2003-04-22 |
Family
ID=21909973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA9900175A OA11143A (en) | 1997-02-11 | 1999-08-10 | Anti-parasitic action of N,N-diethyl-m-toluamide (deet) and formulations that prolong its activity in the skin |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6447801B1 (OSRAM) |
| EP (1) | EP0963198A4 (OSRAM) |
| JP (1) | JP2002511058A (OSRAM) |
| AP (1) | AP9901641A0 (OSRAM) |
| CA (1) | CA2280179A1 (OSRAM) |
| OA (1) | OA11143A (OSRAM) |
| TR (1) | TR199801541A3 (OSRAM) |
| WO (1) | WO1998034604A1 (OSRAM) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| FR2818125B1 (fr) * | 2000-12-19 | 2004-04-02 | Asepta Lab | Composition cosmetique repulsive active contre les furcocercaires de schistosomes |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| ES2532906T5 (es) | 2002-10-25 | 2022-03-23 | Foamix Pharmaceuticals Ltd | Espuma cosmética y farmacéutica |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US20060193789A1 (en) * | 2002-10-25 | 2006-08-31 | Foamix Ltd. | Film forming foamable composition |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| EP2242476A2 (en) | 2008-01-14 | 2010-10-27 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| EP2482788B1 (en) | 2009-10-02 | 2022-12-14 | Journey Medical Corporation | Topical tetracycline compositions |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| CA2978573A1 (en) | 2016-09-08 | 2018-03-08 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4241046A (en) * | 1978-11-30 | 1980-12-23 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4869896A (en) * | 1984-05-30 | 1989-09-26 | Angus Chemical Company | Potentiated insect repellent composition and method |
| US4855090A (en) * | 1987-03-13 | 1989-08-08 | Micro-Pak, Inc. | Method of producing high aqueous volume multilamellar vesicles |
| US5019392A (en) * | 1988-03-03 | 1991-05-28 | Micro-Pak, Inc. | Encapsulation of parasiticides |
| US5173303A (en) * | 1989-05-25 | 1992-12-22 | Technology Unlimited, Inc. | Cutaneous delivery of organic materials |
| US5221535A (en) * | 1989-11-13 | 1993-06-22 | Nova Pharmaceutical Corporation | Sustained release formulations of insect repellent |
| US5145604A (en) * | 1990-09-19 | 1992-09-08 | S. C. Johnson & Son, Inc. | Aqueous emulsion and aerosol delivery system using same |
| JPH06183910A (ja) * | 1992-12-16 | 1994-07-05 | Sumitomo Chem Co Ltd | 害虫忌避剤 |
| FR2715069B1 (fr) * | 1994-01-20 | 1996-04-05 | Rene Laversanne | Procédé pour améliorer la rémanence d'une odeur. |
-
1998
- 1998-02-10 CA CA002280179A patent/CA2280179A1/en not_active Abandoned
- 1998-02-10 EP EP98906225A patent/EP0963198A4/en not_active Withdrawn
- 1998-02-10 AP APAP/P/1999/001641A patent/AP9901641A0/en unknown
- 1998-02-10 JP JP53495098A patent/JP2002511058A/ja not_active Ceased
- 1998-02-10 WO PCT/US1998/002398 patent/WO1998034604A1/en not_active Ceased
- 1998-08-10 TR TR1998/01541A patent/TR199801541A3/tr unknown
-
1999
- 1999-04-01 US US09/283,883 patent/US6447801B1/en not_active Expired - Lifetime
- 1999-08-10 OA OA9900175A patent/OA11143A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0963198A1 (en) | 1999-12-15 |
| AP9901641A0 (en) | 1999-09-30 |
| JP2002511058A (ja) | 2002-04-09 |
| US6447801B1 (en) | 2002-09-10 |
| WO1998034604A1 (en) | 1998-08-13 |
| EP0963198A4 (en) | 2001-08-29 |
| TR199801541A2 (xx) | 2000-03-21 |
| WO1998034604A8 (en) | 2001-02-01 |
| TR199801541A3 (tr) | 2000-03-21 |
| CA2280179A1 (en) | 1998-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6447801B1 (en) | Anti-parasitic action of N,N-diethyl-m-toluamide (deet) and formulations that prolong its activity in the skin | |
| US5346922A (en) | Insect repellent lotions and sprays | |
| JP3233402B2 (ja) | 物質の制御送達用のリポスフェア | |
| Salafsky et al. | study on the efficacy of a new long-acting formulation of N, N-diethyl-m-toluamide (DEET) for the prevention of tick attachment. | |
| Flannigan et al. | Synthetic pyrethroid insecticides: a dermatological evaluation. | |
| IE904098A1 (en) | Lipospheres for controlled delivery of substances | |
| Frances et al. | Efficacy and safety of repellents containing DEET | |
| RU2113119C1 (ru) | Средство для отпугивания насекомых | |
| Salafsky et al. | Development and evaluation of LIPODEET, a new long-acting formulation of N, N-diethyl-m-toluamide (DEET) for the prevention of schistosomiasis. | |
| Maibach et al. | Use of insect repellents for maximum efficacy | |
| US5173303A (en) | Cutaneous delivery of organic materials | |
| CA2080245C (en) | Insect repellent lotions and sprays | |
| MXPA98006381A (es) | Accion anti-parasitaria de n,n-dietil-m-toluamida(deet) y formulaciones que prolongan su actividaden la °piel. | |
| WO1999056548A1 (en) | Insecticide | |
| Salafsky et al. | Evaluation of N, N-diethyl-m-toluamide (DEET) as a topical agent for preventing skin penetration by cercariae of Schistosoma mansoni. | |
| CA2057909C (en) | Cutaneous delivery of organic materials | |
| Salafsky et al. | Lipodeet: An improved formulation for a safe, long-lasting repellent | |
| CN1253774A (zh) | 含有N,N－二乙基－m－甲苯甲酰胺的抗寄生虫组合物 | |
| US12616196B2 (en) | Long protection mosquito repellent ointment | |
| WO2023102357A1 (en) | Insect and non-insect arthropod pest repellent compositions and methods | |
| BR102023012382A2 (pt) | Composição e método para reduzir a permeação cutânea de substâncias repelentes na pele, aumentando a segurança e eficácia de formulações repelentes de mosquito e carrapato | |
| CA1339073C (en) | Penetration enhancement with binary system of cell envelope disordering compounds & lower alcohols | |
| WO2002024182A1 (en) | Ectoparasite formulation | |
| ALEXANDER et al. | CONTAINING DIETHYL TOLUAMIDE (DEET) AND PERMETHRIN AGAINST PHLEBOTOMINE SAND FLIES (DIPTERA: PSYCHODIDAE) | |
| OA20756A (en) | Long protection mosquito repellent ointment. |